From Wikipedia, the free encyclopedia
  (Redirected from MDPR)
Jump to navigation Jump to search
IUPAC name
  • 74698-36-5
3D model (JSmol)
  • Interactive image
  • 486273
ECHA InfoCard 100.217.125
PubChem CID
  • 559375
Molar mass 221.30 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☑Y verify (what is ☑Y‹See TfM›☒N ?)
Infobox references

3,4-Methylenedioxy-N-propylamphetamine (MDPR, "Phantom") is a lesser-known psychedelic drug and a substituted amphetamine. MDPR was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 200 mg, and the duration unknown. MDPR is a promoter; by itself it has almost no effects on the mind, but it promotes the effects of hallucinogens, similarly to the closely related MDPH.

Shulgin reported that 160 mg of MDPR strongly enhanced the effects of a small (60 μg) dose of LSD, and that similar enhancement of hallucinogenic effect was noted when mixing MDPR with other drugs such as psilocybin, mescaline, 2C-B, and 2C-T-7. The reason for this synergistic action of MDPR has not been elucidated. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPR other than what is written in PiHKAL.

See also

External links

  • MDPR entry in PiHKAL
  • MDPR entry in PiHKAL • info
Retrieved from "https://en.wikipedia.org/w/index.php?title=3,4-Methylenedioxy-N-propylamphetamine&oldid=846480843"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/MDPR
This page is based on the copyrighted Wikipedia article "3,4-Methylenedioxy-"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA